| Identification of the breast cancer susceptibility gene BRCA2 R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, ... Nature 378 (6559), 789-792, 1995 | 4889 | 1995 |
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families D Ford, DF Easton, M Stratton, S Narod, D Goldgar, P Devilee, DT Bishop, ... The American Journal of Human Genetics 62 (3), 676-689, 1998 | 3905 | 1998 |
| Localization of a Breast Cancer Susceptibility Gene, BRCA2, to Chromosome 13q12-13 R Wooster, SL Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, ... Science 265 (5181), 2088-2090, 1994 | 2843 | 1994 |
| Genome-wide association study identifies novel breast cancer susceptibility loci DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ... Nature 447 (7148), 1087-1093, 2007 | 2810 | 2007 |
| Consensus: guidelines for diagnosis and therapy of MEN type 1 and type 2 ML Brandi, RF Gagel, A Angeli, JP Bilezikian, P Beck-Peccoz, C Bordi, ... The Journal of clinical endocrinology & metabolism 86 (12), 5658-5671, 2001 | 2564 | 2001 |
| Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A LM Mulligan, JBJ Kwok, CS Healey, MJ Elsdon, C Eng, E Gardner, ... Nature 363 (6428), 458-460, 1993 | 2427 | 1993 |
| Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer NP Carter, CE Bebb, M Nordenskjo, BAJ Ponder, A Tunnacliffe Genomics 13 (3), 718-725, 1992 | 1879 | 1992 |
| The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: International RET Mutation Consortium analysis C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, RF Gagel, ... Jama 276 (19), 1575-1579, 1996 | 1444 | 1996 |
| Catalytic specificity of protein-tyrosine kinases is critical for selective signalling Z Songyang, KL Carraway III, MJ Eck, SC Harrison, RA Feldman, ... Nature 373 (6514), 536-539, 1995 | 1154 | 1995 |
| GDNF signalling through the Ret receptor tyrosine kinase P Durbec, CV Marcos-Gutierrez, C Kilkenny, M Grigoriou, K Wartiowaara, ... Nature 381 (6585), 789-793, 1996 | 1048 | 1996 |
| Polygenic susceptibility to breast cancer and implications for prevention PDP Pharoah, A Antoniou, M Bobrow, RL Zimmern, DF Easton, ... Nature genetics 31 (1), 33-36, 2002 | 1023 | 2002 |
| Family history and the risk of breast cancer: a systematic review and meta‐analysis PDP Pharoah, NE Day, S Duffy, DF Easton, BAJ Ponder International journal of cancer 71 (5), 800-809, 1997 | 987 | 1997 |
| Cancer genetics BAJ Ponder Nature 411 (6835), 336-341, 2001 | 903 | 2001 |
| Mutations of the RET proto-oncogene in Hirschsprung's disease P Edery, S Lyonnet, LM Mulligan, A Pelet, E Dow, L Abel, S Holder, ... Nature 367 (6461), 378-380, 1994 | 902 | 1994 |
| The genetics and genomics of cancer A Balmain, J Gray, B Ponder Nature genetics 33 (3), 238-244, 2003 | 861 | 2003 |
| Oral contraceptives and the risk of hereditary ovarian cancer SA Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, ... New England Journal of Medicine 339 (7), 424-428, 1998 | 857 | 1998 |
| Localization of the gene for Cowden disease to chromosome 10q22–23 MR Nelen, GW Padberg, EAJ Peeters, AY Lin, B Helm, RR Frants, ... Nature genetics 13 (1), 114-116, 1996 | 838 | 1996 |
| Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations SR Lakhani, J Jacquemier, JP Sloane, BA Gusterson, TJ Anderson, ... Journal of the National Cancer Institute 90 (15), 1138-1145, 1998 | 822 | 1998 |
| Familial gastric cancer: overview and guidelines for management C Caldas, F Carneiro, HT Lynch, J Yokota, GL Wiesner, SM Powell, ... Journal of medical genetics 36 (12), 873-880, 1999 | 801 | 1999 |
| Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma BR Seizinger, GA Rouleau, LJ Ozelius, AH Lane, GE Farmer, JM Lamiell, ... Nature 332 (6161), 268-269, 1988 | 796 | 1988 |
